Vasopressor drugs for pulmonary hypertension crisis
Treatments studied
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests whether three common blood pressure medicines (dopamine, norepinephrine, and epinephrine) can help people who are hospitalized with a sudden worsening of pulmonary hypertension, a condition of high blood pressure in the lungs. It aims to find a treatment that can stabilize patients during this dangerous time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH).
- You are currently in the hospital because of a sudden crisis of pulmonary hypertension.
- You are not already receiving one of the study drugs (dopamine, norepinephrine, or epinephrine) through an IV.
- You are not pregnant, do not have uncontrolled thyroid problems, angle-closure glaucoma, or a known allergy to the study drugs.
- You are not taking certain antidepressants or Parkinson's disease drugs (MAOIs) or certain anesthesia gases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug called treprostinil to see if it is safe and effective for people with intermediate-risk pulmonary arterial hypertension (PAH), a condition of high blood pressure in the lungs. If you join, you may receive the study drug along with your usual PAH medications, which could help improve your symptoms and slow the disease.
This study follows people with different types of high blood pressure in the lungs (pulmonary hypertension) to see how starting specific lung blood vessel medicines affects outcomes. It may help improve how clinicians choose and monitor treatment over time.
This trial tests a new medication called REGN13335 for people with pulmonary arterial hypertension (PAH). It aims to see if the drug can improve symptoms and function compared to standard care alone.
This trial compares two medications, vasopressin and norepinephrine, to see which one better controls blood pressure in the lungs after surgery to remove blockages from the lung arteries. The goal is to find a treatment that keeps the lung blood pressure stable while minimizing side effects.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
This trial compares two medicines (dopamine and norepinephrine) to see which works better for raising blood pressure in newborns who have both low blood pressure and high blood pressure in the lungs. Both medicines are given through a vein to help stabilize your baby's blood pressure.
Hear when a new Pulmonary Arterial Hypertension (PAH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.